The medication works primarily by mimicking the naturally occurring GLP-1 hormone, which enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
[1] [2] During the first month of semaglutide treatment, patients typically experience modest but noticeable weight loss as the medication is initiated at lower doses
The peptide is indicated for therapy in overweight or obese adults, in conjunction with a reduced calorie diet and increased physical activity, as well as in obese adolescents aged 12-17 [8]
"We really need to try to get delivery when the shortage is up, so you can get to improving health outcomes for all people." *Rachel's name has been changed to protect her identity.
"It's not their fault, says Garvey
Smits MM, Van Raalte DH